Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989;317:1235-46.

Double-blind Study With Phosphatidylserine (PS) in Parkinsonian Patients With Senile Dementia of Alzheimer's Type (SDAT)

Affiliations
  • PMID: 2690093
Clinical Trial

Double-blind Study With Phosphatidylserine (PS) in Parkinsonian Patients With Senile Dementia of Alzheimer's Type (SDAT)

E W Fünfgeld et al. Prog Clin Biol Res. .

Abstract

Experimental and clinical studies showed that Phosphatidylserine--special preparation from cow's brain by FIDIA, Abano Terme, Italy--is able to influence cerebral changes contributed to the symptoms of senile dementia of Alzheimer's type. The application of the computerized EEG method DYNAMIC BRAIN MAPPING (HZI Research Center, Tarrytown, New York) is able to proof the therapeutic effect of Phosphatidylserine: the acceleration of a slowed EEG in Parkinsonian patients with SDAT. These reactions were seen previous to the favourable clinical influence documented by the Sandoz Clinical Assessment Geriatric Scale (SCAG), which showed a significant amelioration in anxiety, motivation and affectivity by the verum drug. Acute and long-term CEEG results--till 18 months--showed that the so-called Theta anteriorisation can be reduced or even abolished; this is replaced by Alpha waves. Even in preclinical cerebral changes this method open the possibility to show incipient alterations of the brain metabolism. Preliminary therapeutic results leads to this and not prooven hypothesis that prevention or retardation of cerebral ageing might be possible.

Similar articles

See all similar articles

Cited by 2 articles

  • Immunology, autoimmunity, and autoantibodies in Parkinson's disease.
    Benkler M, Agmon-Levin N, Hassin-Baer S, Cohen OS, Ortega-Hernandez OD, Levy A, Moscavitch SD, Szyper-Kravitz M, Damianovich M, Blank M, Chapman J, Shoenfeld Y. Benkler M, et al. Clin Rev Allergy Immunol. 2012 Apr;42(2):164-71. doi: 10.1007/s12016-010-8242-y. Clin Rev Allergy Immunol. 2012. PMID: 21234712
  • Dementia in Parkinson's Disease.
    Anderson KE. Anderson KE. Curr Treat Options Neurol. 2004 May;6(3):201-207. doi: 10.1007/s11940-004-0012-9. Curr Treat Options Neurol. 2004. PMID: 15043803

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback